Biotie Therapies Corp.

(BITI) Trade

By |

Profile

Biotie Therapies Corp is a Finland based biopharmaceutical company engaged in developing and marketing therapies that restore function and improve the lives of people with neurological disorders in Finland and the United States. Its product portfolio includes CVT-301, CVT-427, SYN120, rHIgM22 and BTT1023. CVT-301 is a potential therapy for Parkinson's disease, Advance CVT-427 is a potential acute treatment for a migraine, SYN120 is a therapeutic option for people with Parkinson's disease dementia; and Advance clinical development of rHIgM22, a remyelinating antibody, as a potential treatment for people with MS. Its brand includes AMPYRA and Qutenza.

Contact Information

Website: www.biotie.com
Email: thomas.taapken@biotie.com
Main Phone: +358 22748900
Address: Joukahaisenkatu 6
City / Town: Turku
Country: FIN
Postal Code: 20520

Issuer Information

Exchange: NGS
CEO: Timo Veromaa
Employees: 42
NAICS: Pharmaceutical P


Gathering Data... Please wait

Profile

Biotie Therapies Corp is a Finland based biopharmaceutical company engaged in developing and marketing therapies that restore function and improve the lives of people with neurological disorders in Finland and the United States. Its product portfolio includes CVT-301, CVT-427, SYN120, rHIgM22 and BTT1023. CVT-301 is a potential therapy for Parkinson's disease, Advance CVT-427 is a potential acute treatment for a migraine, SYN120 is a therapeutic option for people with Parkinson's disease dementia; and Advance clinical development of rHIgM22, a remyelinating antibody, as a potential treatment for people with MS. Its brand includes AMPYRA and Qutenza.

Contact Information

Website: www.biotie.com
Email: thomas.taapken@biotie.com
Main Phone: +358 22748900
Address: Joukahaisenkatu 6
City / Town: Turku
Country: FIN
Postal Code: 20520

Issuer Information

Exchange: NGS
CEO: Timo Veromaa
Employees: 42
NAICS: Pharmaceutical P
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 27.96 52 Wk Low 12.43
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 12,261,522.00 EPS (TTM) -4.38 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 53 53 53 53
Low Target Price Estimate 25.6 25.6 25.6 25.6
Mean Target Price Estimate 39.3 39.3 39.3 39.3
Standard Deviation 19.37 19.37 19.37 19.37
Date of Most Recent Estimate 03/21/16 03/21/16 03/21/16 03/21/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.5 2.5 2.5 2.5